HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Jin Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

11/2023Salvage treatment in IDH1 mutated acute lymphoblastic leukemia with venetoclax plus methotrexate and pegaspargase: A case report.
1/2023Olverembatinib in relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia: a study of 5 cases.
1/2023Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
1/2023Venetoclax and blinatumomab based chemotherapy-free treatment in a patient with Philadelphia chromosome-negative acute lymphoblastic leukemia.
12/2022Efficacy and safety of blinatumomab in Chinese adults with Ph-negative relapsed/refractory B-cell precursor acute lymphoblastic leukemia: A multicenter open-label single-arm China registrational study.
1/2022Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia.
1/2022The first report of complete remission following treatment with venetoclax plus prednisone in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
1/2021Case Report: The First Report of NUP214-ABL1 Fusion Gene in Acute Myeloid Leukemia Patient Detected by Next-Generation Sequencing.
10/2020The specific distribution pattern of IKZF1 mutation in acute myeloid leukemia.
2/2020Relapsed/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Jin Research Topics

Disease

115Neoplasms (Cancer)
04/2024 - 01/2004
74Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2024 - 01/2004
43Leukemia
02/2024 - 02/2003
36Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2024 - 08/2004
30Multiple Myeloma
02/2024 - 06/2004
26Disease Progression
12/2023 - 01/2006
24Acute Promyelocytic Leukemia
11/2023 - 03/2007
23BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2024 - 02/2004
23Prostatic Neoplasms (Prostate Cancer)
09/2023 - 08/2010
22Infections
02/2024 - 06/2009
20Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2023 - 11/2006
19Renal Cell Carcinoma (Grawitz Tumor)
12/2020 - 03/2009
18Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2024 - 01/2004
15Inflammation (Inflammations)
01/2024 - 03/2011
15Carcinoma (Carcinomatosis)
01/2021 - 01/2007
14Lymphoma (Lymphomas)
02/2024 - 11/2005
13Neutropenia
01/2023 - 09/2003
12Hemorrhage
05/2024 - 01/2014
12Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2023 - 01/2004
12Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 10/2008
11Carcinogenesis
01/2023 - 07/2007
10Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/2024 - 11/2007
10Neoplasm Metastasis (Metastasis)
11/2023 - 01/2007
10Hypertension (High Blood Pressure)
01/2022 - 11/2007
9Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
12/2023 - 01/2015
9Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2023 - 01/2004
9Philadelphia Chromosome
01/2023 - 10/2016
8Mycoses (Diseases, Fungus)
08/2021 - 01/2016
7Stomach Neoplasms (Stomach Cancer)
05/2024 - 11/2007
7Thrombosis (Thrombus)
10/2023 - 01/2017
7Pain (Aches)
03/2021 - 03/2011
6Pneumonia (Pneumonitis)
11/2023 - 11/2012
6Osteoarthritis
07/2022 - 12/2020
6Thrombocytopenia (Thrombopenia)
01/2022 - 08/2013
6Invasive Fungal Infections
07/2021 - 07/2008
6Anemia
01/2021 - 03/2004
6Erectile Dysfunction
04/2014 - 09/2004
6Chromosome Aberrations (Chromosome Abnormalities)
12/2013 - 12/2004
5B-Cell Lymphoma (Lymphoma, B Cell)
01/2024 - 10/2019
5COVID-19
01/2024 - 01/2020
5Fever (Fevers)
01/2024 - 01/2008
5Aneurysm (Aneurysms)
01/2023 - 05/2014

Drug/Important Bio-Agent (IBA)

33Proteins (Proteins, Gene)FDA Link
03/2024 - 03/2006
22Cytarabine (Cytosar-U)FDA LinkGeneric
03/2024 - 01/2008
21Biomarkers (Surrogate Marker)IBA
05/2024 - 08/2010
21Arsenic Trioxide (Trisenox)FDA Link
10/2022 - 06/2004
20Rituximab (Mabthera)FDA Link
01/2024 - 04/2014
20Imatinib Mesylate (Gleevec)FDA Link
01/2024 - 08/2006
19HomoharringtonineIBA
11/2023 - 07/2007
17MicroRNAs (MicroRNA)IBA
11/2023 - 12/2007
16venetoclaxIBA
03/2024 - 01/2020
16Dexamethasone (Maxidex)FDA LinkGeneric
12/2023 - 10/2008
15Messenger RNA (mRNA)IBA
10/2023 - 02/2003
15Bortezomib (Velcade)FDA Link
01/2023 - 11/2006
14Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2023 - 12/2011
13Tyrosine Kinase InhibitorsIBA
12/2023 - 05/2008
12CytokinesIBA
01/2024 - 01/2004
12Prednisone (Sone)FDA LinkGeneric
01/2023 - 03/2015
11DecitabineFDA Link
01/2023 - 06/2014
10Therapeutic UsesIBA
03/2021 - 01/2006
9EnzymesIBA
02/2024 - 06/2004
9Doxorubicin (Adriamycin)FDA LinkGeneric
09/2023 - 03/2015
9DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2004
9AclarubicinIBA
01/2022 - 01/2008
8LipidsIBA
01/2024 - 06/2012
8Inosine Triphosphate (ITP)IBA
12/2023 - 01/2015
8Agammaglobulinaemia Tyrosine KinaseIBA
11/2023 - 10/2019
8zanubrutinibIBA
11/2023 - 01/2020
8triptolideIBA
09/2023 - 02/2004
8Azacitidine (5 Azacytidine)FDA Link
08/2023 - 06/2018
8Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023 - 03/2015
8Lenalidomide (CC 5013)FDA Link
09/2022 - 06/2013
8Antiviral Agents (Antivirals)IBA
11/2020 - 05/2007
8Sunitinib (Sutent)FDA Link
03/2020 - 03/2010
7RNA (Ribonucleic Acid)IBA
10/2023 - 01/2013
7Interleukin-6 (Interleukin 6)IBA
01/2023 - 09/2008
7Vincristine (Oncovin)FDA LinkGeneric
01/2023 - 03/2015
7ArsenicIBA
10/2022 - 11/2013
7CaspasesIBA
09/2014 - 08/2007
6ibrutinibIBA
09/2022 - 02/2017
6Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
01/2021 - 06/2014
6RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2014 - 01/2006
5Transcription Factors (Transcription Factor)IBA
02/2024 - 09/2015
5Triglycerides (Triacylglycerol)IBA
01/2024 - 01/2008
56-methyladenineIBA
10/2023 - 01/2017
5InterferonsIBA
04/2023 - 08/2013
5AlbuminsIBA
01/2023 - 01/2015
5daratumumabIBA
01/2023 - 01/2021
5Proteasome InhibitorsIBA
12/2022 - 05/2007

Therapy/Procedure

111Therapeutics
02/2024 - 11/2004
48Drug Therapy (Chemotherapy)
03/2024 - 12/2004
12Hematopoietic Stem Cell Transplantation
04/2024 - 12/2016
9Stents
08/2023 - 03/2011
9Prostatectomy (Retropubic Prostatectomy)
01/2019 - 02/2012
8Salvage Therapy
11/2023 - 08/2013
8Nephrectomy
12/2020 - 07/2012
8Induction Chemotherapy
06/2019 - 01/2008
7Castration
09/2023 - 08/2015
7Aftercare (After-Treatment)
08/2020 - 03/2006
6Radiotherapy
12/2023 - 08/2012